Hamburg Says EMA Could Be Model For Global Regulatory Coalition
This article was originally published in The Tan Sheet
The FDA commissioner urges authorities to move away “from an outdated paradigm of only working in our own jurisdiction” in speech at European Medicines Agency’s 20th anniversary meeting.
You may also be interested in...
Hamburg Departure Hinged On Filling FDA Leadership Roster
Susan Mayne brings “new strength and focus to CFSAN and medical countermeasures expert Luciana Borio moves to chief scientist role. Hamburg offers previews on leadership approaches of Stephen Ostroff and Robert Califf.
FDA/EMA Bioequivalence Collaboration Is Narrow In Scope, Wide In Reach
In contrast to the existing inspection program for clinical trials, sites around the globe will be targeted.
Pipeline Watch: Phase III Readouts in Wilson Disease, Parkinson's Disease And COVID-19
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.